GRP
PHAR

Global Retirement Partners’s Pharming Group PHAR Stock Holding History

Global Retirement Partners’s Portfolio PHAR Stock Details PHAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-23
Closed -$334 – 4372
2025
Q3 		$334 Buy
+23
New +$286 ﹤0.01% 3691

Other funds holding PHAR

SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $240M AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
NSG
Nalls Sherbakoff Group Knoxville, Tennessee $139M AUM 21.16% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Global Retirement Partners's PHAR Position: Q4 2025 in Review

Global Retirement Partners sold out of Pharming Group (PHAR) in Q4 2025, closing a stake of 23 shares — an estimated $334 sold.

Global Retirement Partners first reported a position in PHAR in Q3 2025 and held it in 1 quarter. The position peaked at $334 in Q3 2025. 11 funds tracked by Wall St. Rank hold PHAR as of Q4 2025.

  • Global Retirement Partners reported no remaining Pharming Group position as of Q4 2025 after selling out during the quarter.
  • Global Retirement Partners sold 23 Pharming Group shares in Q4 2025, an estimated $334.
  • Global Retirement Partners first reported a position in Pharming Group in Q3 2025 and held it in 1 quarter.
  • Global Retirement Partners's Pharming Group position peaked at $334 in Q3 2025.
  • 11 funds tracked by Wall St. Rank held Pharming Group as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.